Angela Cramer

University of Pittsburgh — United States

Medicine · Health Sciences

10h-index688citations73works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(37), Cancer Cells and Metastasis(24), Advanced Breast Cancer Therapies(24), Breast Cancer Treatment Studies(9), Estrogen and related hormone effects(8)

Publications73 total

Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025Open Access
Table 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025Open Access
Figure 3 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025Open Access
Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025Open Access
Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025Open Access
A Novel Broström-Gould Dual-row Technique for Augmentation
Techniques in Foot & Ankle Surgery·2025
Spatial and single-cell transcriptomics capture two distinct cell states in soybean defense response to Phakopsora pachyrhizi infection
Frontiers in Plant Science·2025· 3 citedOpen Access
Characterizing the Mode of Resistance Conferred Against Asian Soybean Rust by <i>CcRpp1</i> , a Novel <i>R</i> Gene from <i>Cajanus cajan</i>
Phytopathology·2025· 1 cited
Abstract P2-04-30: Harnessing Technology: A Comparative Study of AI versus Manual Scoring in HER2 Ultra-low Breast Cancer
Clinical Cancer Research·2025
Spatial and single-cell transcriptomics capture two distinct cell states in plant immunity
2025· 1 citedOpen Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
Supplementary Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Nigel Bundred(24), Kieran Horgan(17), Jay Naik(17), Jane Ooi(17), David Cameron(17), Judith M. Bliss(17), Adrian Murray Brunt(16), Anne Armstrong(16), David Dodwell(16), Abigail Evans(16), Sue M. Hartup(16), James P. Morden(16), Sankaran Narayanan(16), Núria Porta(15), Andrew M. Hanby(15), Abeer M. Shaaban(15), Emad A. Rakha(15), Ramsey Cutress(15), Marie A. Emson(15), Sarah E. Miller(15)